Literature DB >> 20058622

[Effects of ShenSongYangXin on action potential and some current channels in isolated rabbit pulmonary vein cardiomyocytes].

Liang Shi1, Xin-Chun Yang, Xiu-Lan Liu, Min Zong, Yi-Ling Wu.   

Abstract

OBJECTIVE: To investigate the effects of ShenSongYangXin on action potential and some current channels in isolated rabbit pulmonary vein cardiomyocytes and to elucidate its possible mechanism of curing atrial fibrillation.
METHODS: Action potentials as well as L-type calcium channel current (I(Ca-L)), transient outward potassium current (I(K1)) and inward rectifier potassium current (I(To)) were recorded using whole cell patch-clamp technique.
RESULTS: ShenSongYangXin prolonged the action potential duration (APD) significantly, APD90 was enlarged from (187 +/- 49) ms to (286 +/- 76) ms at the concentration of 5 mg/ml and to (312 +/- 82) ms at the concentration of 10 mg/dl respectively (P < 0.05). It also depressed the current of I(Ca-L), I(K1) and Iro in a concentration-dependent manner.
CONCLUSION: ShenSongYangXin can be used to treat atrial fibrillation through its actions on multiple current channels.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20058622

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  3 in total

Review 1.  Application of Traditional Chinese Medicine in Treatment of Atrial Fibrillation.

Authors:  Yan Dong; Jiangquan Liao; Kuiwu Yao; Wenrui Jiang; Jie Wang
Journal:  Evid Based Complement Alternat Med       Date:  2017-01-24       Impact factor: 2.629

2.  Chinese medicine shensongyangxin is effective for patients with bradycardia: results of a randomized, double-blind, placebo-controlled multicenter trial.

Authors:  Yunfang Liu; Ning Li; Zhenhua Jia; Feng Lu; Jielin Pu
Journal:  Evid Based Complement Alternat Med       Date:  2014-01-16       Impact factor: 2.629

3.  Shensong Yangxin capsule reduces atrial fibrillation susceptibility by inhibiting atrial fibrosis in rats with post-myocardial infarction heart failure.

Authors:  Jin Ma; Chunxia Yin; Shiyu Ma; Huiliang Qiu; Chaoyang Zheng; Qiuxiong Chen; Chunhua Ding; Weihui Lv
Journal:  Drug Des Devel Ther       Date:  2018-10-10       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.